We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.94B
(+19%)
Cap. Flow
+$966M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
880
New
146
Increased
371
Reduced
267
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$249M |
| 2 |
PayPal
PYPL
|
+$72.8M |
| 3 |
MarketAxess Holdings
MKTX
|
+$69.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$69.2M |
| 5 |
NVIDIA
NVDA
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$257M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$110M |
| 3 |
VMW
VMware, Inc
VMW
|
+$83.9M |
| 4 |
TJX Companies
TJX
|
+$72.9M |
| 5 |
CME Group
CME
|
+$62.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 13.02% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Canadian Natural Resources
CNQ
$97.3B
| $18K | ﹤0.01% |
1,527
-5
| -0.3% | -$50 |
|
752
Fluor
FLR
$7.56B
| $18K | ﹤0.01% |
1,127
+27
| +2% | +$382 |
|
|
HEPA
753
DELISTED
Hepion Pharmaceuticals
HEPA
| $18K | ﹤0.01% |
+8
| New | +$20.7K |
|
|
CELL
754
DELISTED
PhenomeX Inc. Common Stock
CELL
| $18K | ﹤0.01% |
+201
| New | +$16.9K |
|
755
Aldeyra Therapeutics
ALDX
$92.9M
| $17K | ﹤0.01% |
2,478
-22
| -0.9% | -$154 |
|
756
PVH
PVH
$4.03B
| $17K | ﹤0.01% |
181
-189
| -51% | -$14.4K |
|
757
iShares Core MSCI EAFE ETF
IEFA
$195B
| $16K | ﹤0.01% |
+232
| New | +$15K |
|
758
Packaging Corp of America
PKG
$22.6B
| $16K | ﹤0.01% |
116
-4
| -3% | -$504 |
|
|
RNTX
759
Rein Therapeutics
RNTX
$66.4M
| $16K | ﹤0.01% |
+769
| New | +$19.2K |
|
760
Nutanix
NTNX
$17.3B
| $13K | ﹤0.01% |
+408
| New | +$11.1K |
|
761
Dyadic International
DYAI
$37.2M
| $11K | ﹤0.01% |
2,045
+45
| +2% | +$296 |
|
|
CYPH
762
Cypherpunk Technologies Inc
CYPH
$72.9M
| $11K | ﹤0.01% |
489
-11
| -2% | -$209 |
|
763
Pinduoduo
PDD
$131B
| $11K | ﹤0.01% |
62
-58
| -48% | -$6.93K |
|
764
Eaton
ETN
$174B
| $10K | ﹤0.01% |
+83
| New | +$9.38K |
|
765
Huntington Ingalls Industries
HII
$13.1B
| $10K | ﹤0.01% |
+59
| New | +$9.37K |
|
766
Kohl's
KSS
$2.17B
| $10K | ﹤0.01% |
246
-4
| -2% | -$116 |
|
767
Lumen
LUMN
$6.66B
| $10K | ﹤0.01% |
1,026
+24
| +2% | +$237 |
|
768
Shake Shack
SHAK
$2.85B
| $10K | ﹤0.01% |
118
-120
| -50% | -$9.31K |
|
769
3D Systems Corp
DDD
$628M
| $9K | ﹤0.01% |
859
+9
| +1% | +$73 |
|
770
Douglas Emmett
DEI
$1.91B
| $9K | ﹤0.01% |
308
+7
| +2% | +$199 |
|
771
Flowers Foods
FLO
$1.52B
| $9K | ﹤0.01% |
398
-23
| -5% | -$536 |
|
772
iShares MSCI India ETF
INDA
$6.61B
| $8K | ﹤0.01% |
+199
| New | +$7.27K |
|
773
Vanguard Energy ETF
VDE
$10.2B
| $8K | ﹤0.01% |
154
+4
| +3% | +$187 |
|
|
DVAX
774
DELISTED
Dynavax Technologies
DVAX
| $7K | ﹤0.01% |
1,573
+74
| +5% | +$335 |
|
775
HSBC
HSBC
$355B
| $7K | ﹤0.01% |
+270
| New | +$6.42K |
|
Similar funds
Bank Julius Baer & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Bank Julius Baer & Co held 880 positions worth $12.2B, up 19% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bank Julius Baer & Co deployed $966M of net new capital in Q4 2020, opening 146 new positions and adding to 371 existing holdings. Its largest new stake was Deckers Outdoor: 641,742 shares worth $30.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $257M trimmed.
- Bank Julius Baer & Co's largest Q4 2020 buy was Deckers Outdoor: 641,742 shares worth $30.7M.
- Bank Julius Baer & Co added most to Thermo Fisher Scientific in Q4 2020, an estimated $249M increase.
- Bank Julius Baer & Co's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $257M.
- Bank Julius Baer & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2020, selling an estimated $110M.
- Bank Julius Baer & Co's ten largest holdings make up 36% of its $12.2B portfolio in Q4 2020.
- Bank Julius Baer & Co opened 146 new positions and closed 78 in Q4 2020.
- Bank Julius Baer & Co's portfolio value rose 19% quarter-over-quarter to $12.2B.
Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.